Evotec Announces Change in Management Board
1. Dr. Craig Johnstone steps down as COO effective December 31, 2024. 2. His leadership significantly shaped Evotec’s operations over the past 12 years. 3. Responsibilities of COO will be redistributed until a new structure is defined. 4. Evotec emphasizes innovative tech and partnerships for drug discovery. 5. The company maintains a strong pipeline with over 200 R&D projects.